CNBC June 21, 2024
Key Points
– Neurotech startup Paradromics will be putting its brain implant on trial next year, as the race to be the leader in the brain-computer interface space heats up.
– The trial would follow competitor Neuralink’s move to implant a chip into a patient’s brain in March.
– Paradromics, which was founded in 2015, anticipates the devices will retail for about $100,000 each.
Neurotech startup Paradromics will be putting its brain implant on trial next year, as the race to be the leader in the nascent brain-computer interface space heats up.
“The brain is a super fascinating organ. We have about 85 billion neurons and every neuron is a million times slower than a computer chip. And yet, the...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices